We will present the case of a 75-year-old woman diagnosed with an amelanotic acral melanoma originating from the left foot relapsed to the lung and to muscular and subcutaneous tissues less than one year after the surgical treatment (pT4bN3c, AJCC 8th ed.) of the primary lesion. Treated with first-line encorafenib + binimetinib, the patient reported a complete response lasting 37 months and followed by a partial response, still ongoing after 19 months, to anti-PD-1 antibody second line therapy.

[Amelanotic acral melanoma originating from the foot: a clinical case.]

Piccin, Luisa
2021

Abstract

We will present the case of a 75-year-old woman diagnosed with an amelanotic acral melanoma originating from the left foot relapsed to the lung and to muscular and subcutaneous tissues less than one year after the surgical treatment (pT4bN3c, AJCC 8th ed.) of the primary lesion. Treated with first-line encorafenib + binimetinib, the patient reported a complete response lasting 37 months and followed by a partial response, still ongoing after 19 months, to anti-PD-1 antibody second line therapy.
2021
File in questo prodotto:
File Dimensione Formato  
19_Piccin.pdf

accesso aperto

Tipologia: Published (Publisher's Version of Record)
Licenza: Accesso libero
Dimensione 236.19 kB
Formato Adobe PDF
236.19 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3462334
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 0
social impact